Ownership history in nVerses Capital, LLC · 6 quarters on record
This page tracks every 13F SEC filing in which nVerses Capital, LLC reported a position in TARSUS PHARMACEUTICALS INC (TARS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 700 | — | 0% | 0.01% | $23K | $59.43 |
| 2025 Q2 | UNCHANGED | 700 | — | 0% | 0.01% | $23K | $40.51 |
| 2025 Q1 | UNCHANGED | 700 | — | 0% | 0.01% | $23K | $51.37 |
| 2024 Q4 | UNCHANGED | 700 | — | 0% | 0.01% | $23K | $55.37 |
| 2024 Q3 | REDUCED | 700 | -1,200 | -63.2% | 0.01% | $23K | $32.89 |
| 2024 Q1 | INITIATED | 1,900 | — | — | 0.17% | $69K | — |
As of 2025 Q4 — sorted by position size